^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    dualCAR-NK19/70

    i
    Other names: dualCAR-NK19/70
    Associations

    News

    Trials
    Company:
    Zhejiang University
    Drug class:
    CD19 inhibitor, NK cell stimulant, CD70 inhibitor
    Related drugs:
    Associations

    News

    Trials
    1year
    Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma (clinicaltrials.gov)
    P1/2, N=48, Recruiting, Aibin Liang，MD，Ph.D.
    New P1/2 trial
    |
    CD70 (CD70 Molecule)
    |
    dualCAR-NK19/70
    over1year
    Clinical Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma (clinicaltrials.gov)
    P1, N=48, Recruiting, Second Affiliated Hospital, School of Medicine, Zhejiang University | Not yet recruiting --> Recruiting
    Enrollment open
    |
    CD20 (Membrane Spanning 4-Domains A1) • CD19 (CD19 Molecule)
    |
    CD19 expression • CD20 negative
    |
    dualCAR-NK19/70
    over1year
    Clinical Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma (clinicaltrials.gov)
    P1, N=48, Not yet recruiting, Second Affiliated Hospital, School of Medicine, Zhejiang University
    New P1 trial
    |
    CD20 (Membrane Spanning 4-Domains A1) • CD19 (CD19 Molecule)
    |
    CD19 expression • CD20 negative
    |
    dualCAR-NK19/70